Reshape Lifesciences Inc.
13F holders, Q2 2025 (June 30)4holders
$2.44avg. 13F price*
At the end of Q2 2025, 4 institutions reported holding Reshape Lifesciences Inc. in their 13F filings. The largest holders were Bank of Montreal ($24K), UBS Group AG ($21K) and Tower Research Capital LLC (TRC) ($1K).
- Company
- Reshape Lifesciences Inc.
- CUSIP
- 76090R408
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $47K |
| Exits | 0 | $0 |
Ownership 4 holders
| Bank of Montreal | 0.00% | New | 10,000 | $24K |
| UBS Group AG | 0.00% | New | 8,576 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 478 | $1K |
| Bank of America Corp. | 0.00% | New | 6 | $15 |
"% of holder's portfolio" is RESHAPE LIFESCIENCES INC's weight in each manager's 13F, not the share of Reshape Lifesciences Inc. the manager owns.